SCHEMBL7873917

SCHEMBL7873917

NC(Cc1cccc2ccccc12)C(=O)OCc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SLC1A3 P43003 1/20 0.51
SLC1A2 P43004 1/20 0.51
SLC1A1 P43005 1/20 0.51
TACR1 P25103 4/20 0.50
CTNNB1 P35222 1/20 0.50
CASP1 P29466 3/20 0.47
TDP1 Q9NUW8 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
HRH4 Q9H3N8 1/20 0.45
METAP2 P50579 1/20 0.44
SLC15A1 P46059 1/20 0.43
FFAR1 O14842 1/20 0.43
AKR1B1 P15121 1/20 0.43
LTA4H P09960 1/20 0.43
LAP3 P28838 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6473973 1.00 SLC1A3 (0.51) SLC1A3SLC1A2SLC1A1TACR1CTNNB1
Hydrochloric Acid SCHEMBL6473967 0.99 SLC1A3 (0.50) SLC1A3SLC1A2SLC1A1TACR1CTNNB1
SCHEMBL903514 0.89 SLC1A3 (0.54) SLC1A3SLC1A2SLC1A1TACR1CTNNB1
Hydrochloric Acid SCHEMBL27923214 0.88 SLC1A3 (0.53) SLC1A3SLC1A2SLC1A1TACR1CTNNB1
SCHEMBL7368179 0.86 TACR1 (0.47) SLC1A3SLC1A2SLC1A1TACR1CTNNB1
SCHEMBL24115492 0.84 CTNNB1 (0.51) SLC1A3SLC1A2SLC1A1TACR1CTNNB1
SCHEMBL8465002 0.83 KMT2A (0.50) SLC1A3SLC1A2SLC1A1TACR1CTNNB1
SCHEMBL3936305 0.83 KMT2A (0.50) SLC1A3SLC1A2SLC1A1TACR1CTNNB1
SCHEMBL7262986 0.83 KMT2A (0.50) SLC1A3SLC1A2SLC1A1TACR1CTNNB1
Hydrochloric Acid SCHEMBL7257593 0.82 KMT2A (0.49) SLC1A3SLC1A2SLC1A1TACR1CTNNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0593559-A1 AROMATIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN THERAPY MERCK SHARP & DOHME LTD. (GB) 1994-04-27 EP claimed
WO-1993001169-A2 AROMATIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN THERAPY MERCK SHARP & DOHME LIMITED (GB) 1993-01-21 WO claimed
US-6329394-B1 5HT3 ANTAGONIST AND NK1 RECEPTORS SUBSTANCE P ANTAGONISTS AND OTHER NEUROKININ ANTAGONISTS, IN THE TREATMENT OF EMESIS. GLAXO GROUP LIMITED (GB) 2001-12-11 US disclosed
US-5547964-A ANTIEMETIC DURING DRUG THERAPY GLAXO GROUP LIMITED (GB) 1996-08-20 US disclosed
US-5472978-A Tachykinin antagonists for treating pain, migraine and antiinflammatory agents MERCK SHARP & DOHME LTD. (GB) 1995-12-05 US disclosed
EP-0615751-A1 Use of tachykinin antagonists in the treatment of emesis GLAXO GROUP LIMITED (GB) 1994-09-21 EP disclosed
EP-0593559-A1 AROMATIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN THERAPY MERCK SHARP & DOHME LTD. (GB) 1994-04-27 EP disclosed
WO-1993001169-A2 AROMATIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN THERAPY MERCK SHARP & DOHME LIMITED (GB) 1993-01-21 WO disclosed